The abnormal cytoplasmic accumulation of TDP-43, correctly called TDP-43 proteinopathy, contributes to neurotoxicity and the oligonucleotides treatment composed of TDP-43 target sequences rescues neurotoxicity (Schieweck et al. 2021; Mann et al. 2019). Here, TARDBP is linked to proteostasis deficiencies.